Tackling Antimicrobial Resistance Together: A Conversation with Dr. Beverley Isherwood

An interview with Dr Beverley Isherwood.

Celldex says antibody drug improves irritable skin condition in Phase 2 test

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 31, 2024

Serious Outcomes of Steatotic Liver Disease Hit Men and Women Differently

Serious outcomes associated with metabolic dysfunction-associated steatotic liver disease (MASLD) — including liver cancer, cirrhosis, heart disease, and more — affect men and women differently,

December 5, 2024

New vaccine protects infant monkeys from diarrhea and promotes growth

A vaccine originally developed to prevent bacteria-caused diarrhea has now also been found to help infant nonhuman primates grow faster, according to a new study

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.